More articles from 01.01 - Clinical problems - no related to asthma or COPD

Evolution of the Use of Noninvasive Mechanical Ventilation in Chronic Obstructive Pulmonary disease
I Sahnoun, T Znegui, I Moussa, I Nouira, S Mkaddem, A Allouch, K Chiraz, M R Guerfallah, S Jameleddine, L Douik Elgharbi, L Douik El Gharbi

European Respiratory Journal Sep 2022, 60 (suppl 66) 4225; DOI: 10.1183/13993003.congress-2022.4225
The evaluation of Exercise Induced Laryngeal Obstruction (EILO) performed by inexperienced physicians
P Carlsen, P Muralitharan, M Vollsæter, I Jansrud Hammer, T Halvorsen, O Drange Røksund, H S Havstad Clemm

European Respiratory Journal Sep 2022, 60 (suppl 66) 4240; DOI: 10.1183/13993003.congress-2022.4240
Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
R Prudente, S Tanni, M Okoshi, F Damatto, F Wehrmeister, L Oliveira, C Breda Neto, L Pagan, M Gatto, L Vieira, L Coelho, D Rezende, L Machado, G Mota, M Gaiato, F Santaella, E Campos, L Hosoume, E Franco, U Weinreich

European Respiratory Journal Sep 2022, 60 (suppl 66) 4510; DOI: 10.1183/13993003.congress-2022.4510
Proadrenomedullin and copeptin are more sensitive and specific biomarkers for the prediction of mortality in stable COPD than fibrinogen: An analysis of the COSYCONET study
S Fähndrich, S Teuteberg, C Herr, H Watz, B Waschki, F C Trudzinski, A Omlor, P Alter, F Seiler, F Biertz, T Welte, H Kauczor, R A Jörres, C F Vogelmeier, R Bals, D Stolz

European Respiratory Journal Sep 2022, 60 (suppl 66) 4292; DOI: 10.1183/13993003.congress-2022.4292
Activity of platelet von Willebrand factor in stable patients with COPD in terms of cardiovascular risk.
O Kovalenko, V Rodionova, O Boiko

European Respiratory Journal Sep 2022, 60 (suppl 66) 3841; DOI: 10.1183/13993003.congress-2022.3841
Correlation between vitamin D and anosmia in post acute Covid syndrome clinic
A O'Connor, C Buckley, M Griffin, A Basirat, J Olaniyi, M Monaghan, S Donnelly, P Mitchell

European Respiratory Journal Sep 2022, 60 (suppl 66) 3824; DOI: 10.1183/13993003.congress-2022.3824
Obesity hypoventilation syndrome prevalence by stages of severity in obese population
D Delample, R Lorblanches, N Molinari, B Benhalima, E Ciomaga, F Sanguignol, A Sabil, M Despeaux

European Respiratory Journal Sep 2022, 60 (suppl 66) 3676; DOI: 10.1183/13993003.congress-2022.3676
Network analysis uncovers relationship between immune profiles and severity of COVID-19
M Sova, E Kriegova, S Genzor, M Kudelka, J Mizera, P Jakubec

European Respiratory Journal Sep 2022, 60 (suppl 66) 3688; DOI: 10.1183/13993003.congress-2022.3688
Unexplained dyspnea by cardiopulmonary exercise test
K H Liendo Martinez, W I Girón Matute, J Garcia De Pedro, J Zichen, L Puente Maestu, P A Benedetti

European Respiratory Journal Sep 2022, 60 (suppl 66) 3944; DOI: 10.1183/13993003.congress-2022.3944
Is lymphopenia a predictive factor of outcomes in COVID-19 patients?
T Znegui, I Sahnoun, I Moussa, S Ben Sassi, C Ksouri, A Allouch, R Guerfallah, L Douik El Gharbi

European Respiratory Journal Sep 2022, 60 (suppl 66) 3922; DOI: 10.1183/13993003.congress-2022.3922

Main menu

User menu

Search

More articles from 01.01 - Clinical problems - no related to asthma or COPD

Pages

Contact us